Izrael - hebrejština - Ministry of Health

vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2 mg/ml - bromhexine

Izrael - hebrejština - Ministry of Health

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines

Izrael - hebrejština - Ministry of Health

eli lilly israel ltd, israel - raloxifene hydrochloride - טבליות מצופות פילם - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

Izrael - hebrejština - Ministry of Health

teva pharmaceutical industries ltd, israel - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.5 mg/ml - tetryzoline - tetryzoline - irritation, burning, reddening, itching of the eye due to allergic or physical causes such as dust, smoke, plants,sun rays.

Izrael - hebrejština - Ministry of Health

abic marketing ltd, israel - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.05 % - tetryzoline - tetryzoline - irritation, burning, reddening, itching of the eye due to allergic or physical causes such as dust, smoke, plants,sun rays.

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - anagrelide as hydrochloride - קפסולות - anagrelide as hydrochloride 0.5 mg - anagrelide - anagrelide - treatment for essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.

Izrael - hebrejština - Ministry of Health

bristol, myers squibb (israel) limited, israel - abatacept - אבקה להכנת תמיסה מרוכזת לעירוי - abatacept 250 mg - abatacept - abatacept - orencia in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who responded inadequately to previous therapy with one or more disease modifying anti rheumatic drugs (dmards) including methotrexate (mtx) or a tnf-alpha inhibitor.a reduction in the progression of joint damage and improvement of physical function have been demonstrated during combination treatment with abatacept and methotrexate.polyarticular juvenile idiopathic arthritis:orencia in combination with methotrexate is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (jia) in paediatric patients 6 years of age and older who have had an insufficient response to other dmards including at least one tnf inhibitor. orencia has not been studied in children under 6 years old.

Izrael - hebrejština - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - pemetrexed as disodium hemipentahydrate - אבקה להכנת תמיסה מרוכזת לעירוי - pemetrexed as disodium hemipentahydrate 500 mg - pemetrexed

Izrael - hebrejština - Ministry of Health

abic marketing ltd, israel - pemetrexed - אבקה להכנת תמיסה מרוכזת לעירוי - pemetrexed 100 mg - pemetrexed

Izrael - hebrejština - Ministry of Health

abic marketing ltd, israel - pemetrexed - אבקה להכנת תמיסה מרוכזת לעירוי - pemetrexed 1000 mg - pemetrexed